By Editor , 1 October 2026
Lutris Pharma's LUT014 Gel Hits 71.8% Success Rate in Phase 2 Rash Trial

Tel Aviv, Israel – October 01, 2026 -- Lutris Pharma reported that its topical B-Raf inhibitor LUT014 achieved Treatment Success in 71.8% of patients with EGFR inhibitor-induced acneiform rash, compared with 38.5% on placebo (p=0.003), in updated Phase 2 data presented at the 35th EADV Congress in Vienna.

By Editor , 1 October 2026

Pensacola, Fla. – October 01, 2026 -- Baptist Health Care and PAM Health have restructured their joint venture, adding 40 acute care beds at Baptist Hospital and building a freestanding 60-bed inpatient rehabilitation hospital at Baptist Medical Park – Nine Mile, pushing Baptist Hospital's total bed count from 279 to 319.

By Editor , 1 October 2026
Mayfair Gold Secures C$310M Macquarie Package for Fenn-Gib Mine

Toronto – October 01, 2026 -- Mayfair Gold Corp. (TSXV: MFG) (NYSE American: MINE) has signed a subscription agreement for a C$10 million strategic equity investment from Macquarie Bank Limited and a non-binding term sheet for a proposed C$300 million project finance facility, bringing the total financing package for its Fenn-Gib Gold Project to up to C$310 million.

By Editor , 1 October 2026
Armadin Raises $255.5M Series B, Valuation Tops $2.5B

Palo Alto, Calif. -- October 1, 2026 -- Armadin, an AI-native cybersecurity company, has raised $255.5 million in a Series B round that pushes its valuation above $2.5 billion just seven months after launching from stealth. The round was co-led by Andreessen Horowitz (a16z) and Accel, with new investors Bain Capital Ventures and Redpoint joining. Existing backers 8VC, Ballistic Ventures, Google Ventures, In-Q-Tel, Kleiner Perkins, and Menlo Ventures also returned, lifting Armadin's total funding to $445 million.

By Editor , 1 October 2026

Birkirkara – October 01, 2026 -- Gentoo Media Inc. has called an Extraordinary General Meeting of Shareholders for 2 November 2026 in Stockholm to approve a capital structure overhaul that would pave the way for a directed share issue fully underwritten by three of its largest shareholders.

By Editor , 1 October 2026

Stockholm – October 01, 2026 -- SciBase Holding AB has closed its rights issue fully subscribed, raising approximately SEK 57.5 million before issue costs to fund continued commercialisation of its Nevisense melanoma-diagnostics platform in the United States.

By Editor , 1 October 2026

Birkirkara, Malta – October 01, 2026 -- Gentoo Media Inc. has locked in commitments worth EUR 100 million to refinance its EUR 91.5 million senior secured bonds maturing 18 December 2026, combining a new EUR 50 million term loan with a fully underwritten EUR 50 million share issue.

By Editor , 1 October 2026

STOCKHOLM – October 01, 2026 -- Ericsson (NASDAQ: ERIC) will publish its third-quarter 2026 financial report at approximately 7:00 AM CEST on October 15, 2026, the Stockholm-based telecom equipment maker confirmed.

Ericsson sets October 15 release date with full PDF financial tables

The company will issue a press release with the complete financial report attached, including detailed tables in PDF format. The report will be posted on Ericsson's investor relations website immediately following the press release.

By Editor , 1 October 2026
Fresenius Takes Full Ownership of mAbxience in Biosimilars Push

Madrid – October 01, 2026 -- Fresenius SE & Co. KGaA has completed the acquisition of the remaining 45% stake in mAbxience from Insud Pharma, giving the German healthcare group full ownership of the Spanish biosimilars manufacturer.